Page last updated: 2024-11-01

ofloxacin and Anaplasma Infection

ofloxacin has been researched along with Anaplasma Infection in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wormser, GP1
Filozov, A1
Telford, SR1
Utpat, S1
Kamer, RS1
Liveris, D1
Wang, G1
Zentmaier, L1
Schwartz, I1
Aguero-Rosenfeld, ME1

Other Studies

1 other study available for ofloxacin and Anaplasma Infection

ArticleYear
Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.
    Vector borne and zoonotic diseases (Larchmont, N.Y.), 2006,Winter, Volume: 6, Issue:4

    Topics: Aged; Anaplasma phagocytophilum; Anaplasmosis; Animals; Anti-Bacterial Agents; Disease Models, Anima

2006